Skip to main content

Bellerophon Therapeutics, Inc.

BLPHDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001600132

Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Bellerophon Therapeutics, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of BLPH: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders1923+4
Shares3.53M1.20M−2.34M (−66.1%)
Value$27.9M$824.9K−$27.1M (−97.0%)

New holders (11)

Institutions that held Bellerophon Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to BLPH in Q2 2023
InstitutionSharesValue% of portfolio
Acadian Asset Management LLC265,253$182.0K0.00%
Two Sigma Investments, LP103,787$71.6K0.00%
Virtu Financial LLC25,870$18.0K0.00%
Two Sigma Advisers, LP14,900$10.3K0.00%
Raymond James & Associates11,097$7.66K0.00%
Two Sigma Securities, LLC10,355$7.14K0.00%
PFS Partners, LLC6,000$4.14K0.00%
Group One Trading, L.P.3,900$2.69K0.00%
GPS Wealth Strategies Group, LLC38$270.00%
Simplex Trading, LLC95$00.00%
Sofos Investments, Inc.1––

Sold out (7)

Institutions that held Bellerophon Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of BLPH in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Perceptive Advisors LLC930,000$7.34M
Tang Capital Management LLC893,974$7.05M
Dimensional Fund Advisors LP13,585$107.2K
NTV Asset Management LLC12,950$102.2K
Destination Wealth Management10,000$78.9K
Northwestern Mutual Wealth Management Co500$3.94K
Proequities, Inc.40$315